Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
News

Novo Nordisk to buy two pharma research companies

August 27, 2015 Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
News
md_anderson_cancer_center

Immatics and MD Anderson launch new company to develop ACR therapies

August 27, 2015 Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda

Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
News
alimta

Lilly defeats Teva in US court over Alimta patent

August 26, 2015 Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer

Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …
News
artist's impression

Novo Nordisk plans $2bn expansion of production facilities

August 26, 2015 Manufacturing and Production, Research and Development Novo Nordisk, manufacturing

Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
News
crossroads

After the legal case – where next for pharma industry transparency?

August 26, 2015 Research and Development clinical trial transparency, clinical trials, health research authority, transparency

Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
Feature
novonordiskhq

Novo Nordisk abandons Victoza submission after mixed T1D results

August 26, 2015 Research and Development Novo Nordisk, Victoza, diabetes, insulin

Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …
News
Ebola virus

Researchers hopeful experimental antiviral treatment stops Ebola

August 26, 2015 Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
News
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
News
sean_bohen

AZ appoints Genentech’s Sean Bohen as chief medical officer

August 25, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen

AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …
Appointment

Clinical Trial Transparency – A Personal View

August 24, 2015 Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency

During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …
Feature
research lab

AstraZeneca cancer drug trialled for pancreatic cancer

August 24, 2015 Research and Development

AstraZeneca is working with the Banner MD Anderson Cancer Center in Arizona to test its cancer drug Lynparza as a …
News
Logos

AstraZeneca and Peregrine in immuno-oncology collaboration

August 24, 2015 Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours

AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …
News

Takeda gets European MAA approval for ixazomib

August 21, 2015 Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma

Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …
News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026